Cargando…
Inhibition of human immunodeficiency virus type-1 (HIV-1) glycoprotein-mediated cell-cell fusion by immunor (IM28)
BACKGROUND: Immunor (IM28), an analog of dehydroepiandrosterone (DHEA), inhibits human immunodeficiency virus type-1 (HIV-1) by inhibiting reverse transcriptase. We assessed the ability of IM28 to inhibit the cell-cell fusion mediated by HIV envelope glycoprotein in an in vitro system. For this purp...
Autores principales: | Mavoungou, Donatien, Poaty-Mavoungou, Virginie, Akoume, Marie-Yvonne, Ongali, Brice, Mavoungou, Elie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC552330/ https://www.ncbi.nlm.nih.gov/pubmed/15707492 http://dx.doi.org/10.1186/1743-422X-2-9 |
Ejemplares similares
-
Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?
por: Moreth, Jens, et al.
Publicado: (2013) -
Is abeta a sufficient biomarker for monitoring anti-abeta clinical studies? A critical review
por: Moreth, Jens, et al.
Publicado: (2013) -
The quality of reporting general safety parameters and immune-related adverse events in clinical trials of FDA-approved immune checkpoint inhibitors
por: Karimian, Zahra, et al.
Publicado: (2020) -
P06-03. The Buea University develops HIV clinical trial capacity within the Cental African Network on TB, HIV/AIDS and malaria, CANTAM
por: Ndumbe, PM, et al.
Publicado: (2009) -
Prevalence and therapeutic management of snakebite cases in the health facilities of the Bouenza department from 2009 to 2021, Republic of Congo
por: Mavoungou, Lise Bethy, et al.
Publicado: (2022)